In Vitro Activities of New Antimicrobials against Nocardia brasiliensis
AUTOR(ES)
Vera-Cabrera, Lucio
FONTE
American Society for Microbiology
RESUMO
The in vitro sensitivities of 30 strains of Nocardia brasiliensis to DA-7867, gatifloxacin, moxifloxacin, and BMS-284756 (garenoxacin) were determined using the broth microdilution method. All N. brasiliensis strains were sensitive to these antimicrobials. The most active drug in vitro was DA-7867, with a MIC at which 90% of the isolates tested were inhibited of 0.03 μg/ml and a MIC at which 50% of the isolates tested were inhibited of 0.06 μg/ml.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=321515Documentos Relacionados
- In Vitro and In Vivo Activities of Antimicrobials against Nocardia brasiliensis
- In Vitro Activity of PNU-100766 (Linezolid), a New Oxazolidinone Antimicrobial, against Nocardia brasiliensis
- In Vitro Activities of Linezolid against Multiple Nocardia Species
- In Vitro Activities of ABT-773 and Other Antimicrobials against Human Mycoplasmas
- Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes.
